Review compares cannabis and tobacco use disorders and their treatment options

Tobacco and Cannabis Use Disorders: Similarities, Differences and Therapeutic Approaches.

Annual review of pharmacology and toxicology β€’ β€’ Review β€’ Highly Relevant
πŸ€–

AI Summary

This paper reviews similarities and differences between cannabis use disorder (CUD) and tobacco use disorder (TUD), along with approaches to diagnosis and treatment. It describes both disorders as involving compulsive use despite harm and changes in reward and motivational circuitry. The abstract reports no sample size or quantitative results, consistent with a review rather than a reported clinical trial.

The review says CUD and TUD share involvement of the dopaminergic reward system, withdrawal symptoms, and mental health comorbidities, but differ in neurobiology, diagnostic profiles, and available medications. It notes that co-use is common and can affect disorder severity and outcomes, and that approved medications exist for TUD but not yet for CUD; management may combine pharmacological and psychosocial approaches. This is an abstract-based summary: the abstract does not specify the review methods or assess the strength of evidence behind particular treatments, so it cannot establish treatment effectiveness.

πŸ’‘ Key Findings

1
Cannabis and tobacco use disorders share features including reward-system involvement, withdrawal symptoms, and mental health comorbidities.
High
90%
2
The review describes differences between the disorders in neurobiological pathways, diagnostic profiles, and available pharmacotherapies.
High
90%
3
The abstract states that approved medications are available for TUD but not yet for CUD, and describes management as potentially integrating medication and psychosocial interventions.
High
90%
4
Co-use of cannabis and tobacco is described as common and as influencing disorder severity and outcomes.
High
90%

πŸ“„ Original Abstract

Cannabis and tobacco are two of the most commonly used drugs worldwide. Both drugs can lead to a use disorder, characterized by compulsive use despite harm and mediated by neurobiological changes in reward and motivational circuitry. Co-use of cannabis and tobacco is common and influences disorder severity and outcomes. Both cannabis use disorder (CUD) and tobacco use disorder (TUD) share key features, such as dopaminergic reward system involvement, severity of withdrawal symptoms, and mental health comorbidities, yet they differ in neurobiological pathways, diagnostic profiles, and available pharmacotherapies. Diagnostic frameworks like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, and International Classification of Diseases 11 provide standardized criteria for assessment. Optimal management integrates pharmacological and psychosocial interventions, though approved medications exist for TUD and not yet for CUD. Understanding similarities, distinctions, and treatment strategies is critical for effective prevention and clinical care.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.